<DOC>
	<DOCNO>NCT00006209</DOCNO>
	<brief_summary>The purpose study see safe give tucaresol HIV-infected patient take combination anti-HIV therapy ( HAART ) . This study also examine effect tucaresol viral load ( level HIV body ) tucaresol use HAART .</brief_summary>
	<brief_title>A Study Tucaresol HIV-Infected Patients Who Are Taking Other Anti-HIV Drugs</brief_title>
	<detailed_description>Patients enrol sequentially next available dosage cohort . Each cohort receive single dose tucaresol , observe 2 week , receive 3 alternate-day dos drug careful safety monitoring , include 4 week follow-up final dose . Dose cohort receive drug sequentially , lowest-dose cohort receive drug first . Dose escalation may proceed next higher-dose cohort patient prior lower-dose cohort complete 4-week follow-up multiple dosing , adverse event within described bound , FDA review safety information treat cohort approve dose escalation . The drug administer 4 time within 8 week study period . Weekly visit require . Patients receive financial compensation .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Inclusion Criteria Patients may eligible study : Are least 18 year old . Are HIVpositive . Have 300 CD4 T cells/microL screening . Are take certain antiHIV drug . Have take antiHIV drug successfully least 6 month . Do expect change antiHIV therapy study . Have plasma viral load le 50 copies/ml antiHIV therapy . Have viral load detect screening baseline test . Are able complete weekly visit . Exclusion Criteria Patients eligible study : Can give informed consent . Have abnormal laboratory test result baseline . Are pregnant breastfeeding . Have certain shortterm longterm illness ( heart disease , sickle cell disease , anemia , lung problem ) . Have receive vaccination within 30 day prior enrollment . Have receive experimental drug within 60 day enrollment . Are take abacavir ( Ziagen , GW1592 ) drug affect immune system , IL2 , GMCSF , corticosteroid , cyclosporine . Have history tumor . Are actively use illegal drug ( methadone allow ) . Have hepatitis B hepatitis C .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2001</verification_date>
	<keyword>HIV-1</keyword>
	<keyword>Immunity , Cellular</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>CD4-Positive T-Lymphocytes</keyword>
	<keyword>Antigens</keyword>
	<keyword>Anti-HIV Agents</keyword>
	<keyword>Viral Load</keyword>
	<keyword>tucaresol</keyword>
</DOC>